Wegovy
About
Wegovy is a GLP-1 receptor agonist medication developed by Novo Nordisk for the treatment of obesity and overweight conditions. It functions by mimicking hormones that target areas of the brain that regulate appetite and food intake.
Technology stack
detected 2026-07-04Emailnone
Stack
Tailwind CSS
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Wegovy do?
Wegovy is a GLP-1 receptor agonist medication developed by Novo Nordisk for the treatment of obesity and overweight conditions. It functions by mimicking hormones that target areas of the brain that regulate appetite and food intake.
Where is Wegovy headquartered?
Wegovy is headquartered in Bagsværd, Denmark.
What industry does Wegovy operate in?
Wegovy operates in Biotech, HealthTech, MedTech, Drug Discovery.